4th Quarter - Report

MEHLMAN CONSULTING, INC. for ASTRAZENECA PHARMACEUTICALS

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Discussions and possible legislation regarding possible increase in Medicaid program base rebate rate issues arising from Deficit Reduction Act. Discussions and possible legislation amending Title SVIII, Part D (Medicare Part D) of SSA, including issues of "non-interference clause," protected classes of drugs, and Medicare Advantage. S.301 and H.R.6331, The Medicare Improvements for Patients and Providers Act S.3118, The Preserving Access to Medicare Act Legislation to address physician payments issues, including SGR and related provisions to Medicare package.

LobbyistCovered position, as disclosed
KELLY RUCKER BINGEL —
JAMIE BROWN —
DAVID CASTAGNETTI —
COLETTE DESMARAIS —
ELISE FINLEY PICKERING —
JONATHAN RUSSELL HOGANSON —
BRUCE MEHLMAN —
STACEY RAMPY —
DEAN ROSEN —
DAVID R THOMAS —
ALLEN L THOMPSON New Sr Prof Staff, House Cmte on Homeland Security
ALEX VOGEL —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 6331 (110th), S. 3118 (110th), S. 301 (110th)

Health Issues HCR

S.558 and H.R.1424, The Mental Health Parity Act of 2007 (regarding requirement for health plans and employers to provide mental health insurance coverage comparable to that of traditional medical coverage). S.2209, Physician Payments Sunshine act of 2007; Grassley/Kohl Bill (regarding proposal to require pharmaceutical manufacturers to disclose provision of items of value to physicians on an annual basis). DOD Tricare issues, including retail pharmacy rebate and other related issues. Comparative Effectiveness: Senate proposal regarding use of comparative effectiveness in health care coverage and/or reimbursement. Genetic Information Nondiscrimination Act Information regarding company patient assistance program Health care reform Legislation to fund cancer research, cancer supportive services and improve access to coverage under 340B program, regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services.

LobbyistCovered position, as disclosed
KELLY RUCKER BINGEL —
JAMIE BROWN —
DAVID CASTAGNETTI —
COLETTE DESMARAIS —
ELISE FINLEY PICKERING —
JONATHAN RUSSELL HOGANSON —
BRUCE MEHLMAN —
STACEY RAMPY —
DEAN ROSEN —
DAVID R THOMAS —
ALLEN L THOMPSON New Sr Prof Staff, House Cmte on Homeland Security
ALEX VOGEL —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 558 (110th), H.R. 1424 (110th), S. 2209 (110th)

Trade (domestic/foreign) TRD

International trade issues, including free-trade agreements; import safety.

LobbyistCovered position, as disclosed
KELLY RUCKER BINGEL —
JAMIE BROWN —
DAVID CASTAGNETTI —
COLETTE DESMARAIS —
ELISE FINLEY PICKERING —
JONATHAN RUSSELL HOGANSON —
BRUCE MEHLMAN —
STACEY RAMPY —
DEAN ROSEN —
DAVID R THOMAS —
ALLEN L THOMPSON New Sr Prof Staff, House Cmte on Homeland Security
ALEX VOGEL —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

Tax issues, including extension of the Research and Development Tax Credit.

LobbyistCovered position, as disclosed
KELLY RUCKER BINGEL —
JAMIE BROWN —
DAVID CASTAGNETTI —
COLETTE DESMARAIS —
ELISE FINLEY PICKERING —
JONATHAN RUSSELL HOGANSON —
BRUCE MEHLMAN —
STACEY RAMPY —
DEAN ROSEN —
DAVID R THOMAS —
ALLEN L THOMPSON New Sr. Prof Staff, House Cmte on Homeland Security
ALEX VOGEL —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Pharmacy PHA

Support of sufficient funding for the Food and Drug Administration to conduct meaningful and effective review of direct-to-consumer advertising.

LobbyistCovered position, as disclosed
KELLY RUCKER BINGEL —
JAMIE BROWN —
DAVID CASTAGNETTI —
COLETTE DESMARAIS —
ELISE FINLEY PICKERING —
JONATHAN RUSSELL HOGANSON —
BRUCE MEHLMAN —
STACEY RAMPY —
DEAN ROSEN —
DAVID R THOMAS —
ALLEN L THOMPSON New Sr Prof Staff, House Cmte on Homeland Security
ALEX VOGEL —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.